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INTRODUCTION 56
Liver sinusoidal endothelial cells (LSEC) play important roles in regulating liver function. LSEC 57 line capillaries of the microvasculature and possess fenestrae to facilitate filtration between the 58 liver parenchyma and sinusoid by serving as a selectively permeable barrier (7, 23) . This role is 59 augmented by high endocytic uptake rates, making LSEC effective scavengers for molecules 60 such albumin, acetylated low density lipoproteins, hyaluronan and antigens in the bloodstream 61 (22, 23, 26, 34, 40, 43) . Furthermore, LSEC have a phenotype unique from traditional vascular 62 endothelial cells, such as pan-endothelial marker CD31 localized only to endosomes in 63 differentiated, unstimulated LSEC (18) . Differentiated LSEC are capable of affecting resident 64 liver cell proliferation, survival, or maintaining their quiescence. As such, loss of function may 65 underlie various hepatic pathologies (7, 16, 24, 33, 50, 57) . 66 67 LSEC are also targets or facilitators of infection and toxicological damage to liver (5). In 68 addition to intrinsically vital contributions they make to proper liver tissue function in vivo, 69 cultured LSEC are important to consider as essential non-parenchymal components of ex vivo 70 tissue engineered models of liver physiology, which are of emerging importance in drug 71 discovery and development (19, 29, 47, 51) . 72 73 Despite this importance, much of LSEC biology remains unknown because they are difficult to 74 maintain in a differentiated state for prolonged periods in vitro. Conventional endothelial 75 culturing techniques are not as successful with LSEC; low serum concentrations (5%) can be 76 toxic and cells die within 48 to 72 hours in serum-free monocultures even in the presence of 77 VEGF (21, 31) . Previously, attempts at serum-free LSEC culture resulted in cell viability 78 maintenance from 6 up to 30 days with surviving cells maintaining endocytic uptake (20, 21, 31) . 79
Receptor mediated endocytic uptake is a characteristic feature of endothelial phenotype, but is 80 insufficient for specific characterization of LSEC differentiation as large venule endothelial cells 81 in the liver, as well as several vascular endothelial cells also exhibit this function (21, 28, 40, 41, 82 54) . Another rat study was also able to prolong cell survival in vitro with use of multiple growth 83 factors such as FGF, hepatocyte growth factor, and PMA within the context of hepatocyte-84 conditioned medium (31) . Human LSEC cultures have been reported to be sustained for long 85 periods, however, these LSEC were positively selected for, or had a higher expression of CD31, 86 a marker of LSEC dedifferentiation (14, 32) . There are also controversies regarding phenotyping 87 human LSEC, as there are reports of heterogeneous expression of surface markers used to 88 characterize LSEC, such as von Willebrand Factor and immunological markers (21) . 89 90 This study tested the hypothesis that an alternative approach emphasizing non-protein 91 components could be beneficial in maintaining LSEC function in culture. Due to the location of 92 the liver downstream of the intestinal tract and a center for lipid metabolism (10), we 93 hypothesized that LSEC require lipids to maintain cell viability. We found that even in serum-94 free, minimal growth factor (i.e., solely VEGF) media, free fatty acids (FFAs) were able to 95 sustain LSEC culture. The addition of lipid supplements to serum-free media with 50 ng/mL 96 VEGF allowed us to bypass the critical time point between 48 and 72 hours when most 97 differentiated LSEC die in vitro. We identified oleic acid (OA) as a major contributing agent 98 responsible for enhancing this survival. OA and lipids in culture could also eventually induce 99 proliferation of cells with LSEC phenotype to confluency, although OA alone was insufficient 100 for maintaining long-term confluent cultures. Furthermore, our results indicate that OA and 101 lipids can maintain multiple LSEC phenotype markers simultaneously for at least 5 days in 102 culture. Our findings indicate that OA and lipids influence early Akt/PKB signaling to mediate 103 cell survival, while late ERK signaling is necessary in culture for viability and proliferation to 104 persist. 105
106

MATERIALS AND METHODS 107
Chemically Defined Culture Media 108 Serum/growth factor-free base medium was made as described with modifications (27, 31) . Low 109 glucose DMEM (Invitrogen, Carlsbad, CA) was supplemented with 0.03g/L L-proline, 0.10g/L 110 L-ornithine, 0.305 g/L niacinamide, 1 g/L glucose, 2 g/L galactose, 2 g/L BSA, 50 μg/mL 111 gentamicin (Sigma-Aldrich, St. Louis, MO), 1 mM L-glutamine (Invitrogen), 5 μg/mL insulin-5 112 μg/mL transferrin-5 ng/mL sodium selenite (Roche Applied Science, Mannheim, Germany Care. Cells were isolated using a two-step collagenase perfusion (27, 47) using Liberase 129 Blendzyme (Roche Applied Science) in place of collagenase. The liver was perfused initially at 130 25 mL/min and reduced down to 15 mL/min flow rates in calcium free 10 mM HEPES (Sigma-131 Aldrich) buffer followed by 10 mM HEPES buffer with Blendzyme for cell isolation. The 132 supernatant cell suspension from the perfusion was used to isolate LSEC at room temperature (6, 133 27 ). Very briefly, supernatant suspensions were spun down at 50 x g for 3 minutes. Supernatants 134 were spun at 100 x g for 4 minutes. Supernatants following the spin were pelleted at 350 x g for 135 10 minutes and resuspended in 20 mL modified HGM without VEGF. The suspension was 136 loaded over 25%/50% Percoll (Sigma-Aldrich)/PBS layers and centrifuged at 900 x g for 20 137 minutes. The interface between the Percoll layers were taken and resuspended with 1:1 modified 138 HGM without VEGF before being spun down at 950 x g for 12 minutes. This LSEC enriched 139 pellet was then resuspended into modified HGM with 25 ng/mL VEGF and 2% FBS 140 (Hyclone/Thermo Fisher Scientific, South Logan, UT). Cells were counted using Sytox Orange 141 exclusion and Hoechst 33342 (Invitrogen) staining on disposable hemacytometers (inCyto, 142 Seoul, Korea). LSEC were then seeded onto 10 μg/mL fibronectin (Sigma-Aldrich) coated tissue 143 culture plates at 400,000 cells/cm 2 . Four to six hours following seeding, culture media were 144 changed with serum-free modified HGM supplemented with VEGF. Metabolic activity of LSEC was assessed over the time period of 5 days using Alamar Blue 156 (Invitrogen) reduction assays. Positive reference standards were first made by heating base 157 modified HGM at 125 °C with 10% Alamar Blue until the entire reagent was oxidized and 158 converted to a bright shade of red. On the days of analysis, 10% Alamar Blue reagent was 159 introduced to each well and allowed to incubate at 37 °C, 5% CO 2 for 6 hours prior to screening 160 in a SpectraMax E2 (MDS Analytical Technologies, Sunnyvale, CA) fluorescent plate reader. 161
Reference standards were included on each plate as positive controls and served as a point of 162 reference in interpreting results. Fluorescent measurements were read by exciting the samples at 163 530 nm and reading the emission wavelengths at 590 nm. Samples were pooled across 3 164 biological replicates (5 technical replicates) for a total of 15 data points. All data points were 165 normalized to blank readings prior to relative comparison to control samples. 166 167 Acetylated-LDL Uptake Assay 168 LSEC were grown on Thermanox coverslips (Nalgene Nunc, Rochester, NY) coated with 10 169 μg/mL fibronectin. On day 5, SECs were incubated for four hours with 10 μg/mL 1,1' 170 dioctadecyl 3,3,3',3' tetramethylindo carbocyanine perchlorate labeled acetylated LDL (Di-I-Ac-171 LDL) (Biomedical Technologies, Inc., Stoughton, MA). Cells were washed several times with 172 probe free modified HGM then rinsed with PBS. LSEC were fixed for 30 minutes in 3% 173 paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA), rinsed with PBS, mounted on 174 glass slides with Fluormount (Sigma-Aldrich), and sealed with nail polish. Samples were 175 compared with positive controls using human dermal microvascular endothelial cells 176 (HDMVEC) (Lonza Inc., Allendale, NJ). 177
178
Immunofluorescence Microscopy 179 LSEC were cultured for up to 5 days on Thermanox coverslips coated with 10 μg/mL 180 fibronectin. Samples were rinsed with PBS and fixed in 3% paraformaldehyde in PBS for 30 181 minutes. Following fixation, samples were rinsed three times with PBS and permeabilized with 182 0.1% Triton X-100 (Sigma-Aldrich) for one hour, excluding samples immunostained for CD31 183 which were not permeablized so as to evaluate only surface expression. Following 184 permeabilization, samples were rinsed three times with 2% BSA in 0.1% Tween-20 in PBS 185 (PBS-T). Samples were blocked with 5% goat or donkey serum (Jackson ImmunoResearch, 186 West Grove, PA) in 2% BSA PBS-T for 1 hour before overnight incubation at 4 °C with primary 187 antibodies for anti-rat CD32b/SE-1 (IBL America, Inc., Minneapolis, MN) at 1:100, 188 CD31/PECAM-1 (Chemicon/Millipore, Temecula, CA) at 1:100, and PCNA (Abcam, 189 Cambridge, MA) at 1:600. The following day, samples were rinsed 3 times in 2% BSA PBS-T 190 before a 1 hour incubation step with secondary AlexaFluor 488/555 (Invitrogen) antibodies at 191 1:250. Coverslips were then rinsed in 2% BSA PBS-T and stained with 1:500 Hoechst. 192
Following incubation with secondary antibodies, samples were rinsed once in 2% BSA PBS-T 193 prior to being treated briefly with nuclear Hoechst staining for 1 minute. Following Hoechst 194 staining, samples were rinsed twice in normal PBS before being mounted onto glass slides with 195 Twenty-four hours before harvesting, 10 μM of 5-ethynyl-2'-deoxyuridine (EdU) (Invitrogen) 204 was added to all conditions. Samples were detached with 0.025% Trypsin (Invitrogen) the 205 following day, quenched with media containing 10% FBS, and immediately spun down at 1,600 206 rpm for 5 minutes. Cells were washed in PBS before being fixed in 2% paraformaldehyde in 207 PBS for 15-30 minutes at room temperature. LSEC were centrifuged and resuspended in 1% 208 BSA in PBS and incubated with primary CD32b antibody (1:100) prior to use of the Click-iT 209 EdU kit, following manufacturer's instructions. Samples were analyzed on an Accuri-C6 210 (Accuri Cytometers, Inc., Ann Arbor, MI) flow cytometer and processed using FlowJo software 211 (FlowJo, Ashland, OR). HDMVEC were used as a negative control population. Total and 212 cellular events were captured with gates created using forward and side scatter data from 213 HDMVEC populations. Following this, CD32b and EdU gates were designated using the double 214 negative HDMVEC population. 215
216
Western Blotting 217 LSEC were harvested on day 5 of culture by incubating with cell lysis buffer (46) for 30 minutes. 218
Cell lysis buffer consisted of 1% Triton X-100, 50mM β-glycerophosphate, 10 mM sodium 219 pyrophosphate, 30 mM sodium fluoride (Sigma-Aldrich), 50 mM Tris (Roche Applied Science), 220 150 mM sodium chloride, 2 mM EGTA, 1 mM DTT, 1 mM PMSF, 1% Protease Inhibitor 221
Cocktail and 1% Phosphatase Inhibitor Cocktails (Sigma-Aldrich). Samples were spun down at 222 12,000 rpm for 12 minutes at 4 °C and supernatants were reserved. Total protein content of 223 sample lysates was determined using micro bicinchoninic acid kits (Thermo Fisher Scientific, 224 Rockford, IL) before being loaded onto the NuPage Novex system (Invitrogen). Lysates were 225 loaded with 6X reducing buffer (Boston BioProducts, Worcester, MA) in 4%-12% Bis-Tris gels 226 (Invitrogen) and transferred to polyvinylidene fluoride membranes (Bio-Rad, Hercules, CA). 227
Membranes were blocked with 5% BSA in PBS-T and incubated with antibodies for β-actin 228
(1:5000), phosphoERK1/2 (1:5000), ERK1/2 (1:5000), phosphoAkt (1:1000), and Akt (1:5000) 
RESULTS
245
FFA lipids support cell survival past the first 48 hours in serum free media. 246 Isolated LSEC were plated and cultured using different lipid supplements of 50 μM OA or 1% 247 lipid (a cocktail of saturated and unsaturated fatty acids) ( Figure 1 ). Immunofluorescence 248 staining of LSEC 24 hours after isolation indicated high purity of LSEC ( Figure 5C ). Distinct 249 morphological changes were observed starting on day 3 in cultures with 50 μM OA or 1% lipid 250 supplement, compared to control cultures ( Figure 1A, B) . Notably, LSEC cultured with 1% lipid 251 underwent proliferation, and by day 5, the culture was at or near confluency. Both regular and 252 FFA-free BSA were evaluated to account for potential variability of BSA-bound lipids. Medium 253 supplemented with 50 μM OA yielded similar results as 1% lipid at day 5 in regular BSA. When 254 FFA-free BSA was used, cells treated with 50 μM OA died after day 4 of culture ( Figure 1C, D) , 255 although this was not observed with regular BSA. Untreated cells took on a granular appearance 256 indicating that lipid moiety is a critical component for LSEC viability (Figure 1B, D) . Granular 257 morphology was also observed in LSEC cultured with PC and LPC (data not shown). 258 259 Live/Dead images of LSEC across conditions in both regular and FFA-free BSA were taken 260 during five days of culture (Figure 2A FFAs support metabolic and endocytic functionality in LSEC past day 3. 275 OA and lipid supplement supported significantly higher Alamar Blue reduction relative to 276 control, in agreement with live/dead stain results ( Figure 3A) . These trends were also observed 277 in FFA-free BSA cultures ( Figure 3B ). Endocytic capacity was measured using Di-I-Ac-LDL 278 uptake as a functional assay for endothelial phenotype (Figure 3C ). OA and lipid treatments 279 sustained high endocytic uptake at day 5; cells positive for nuclear Hoechst were also strongly 280 positive for Di-I-Ac-LDL. Many cells in the control did not remain after fixation; those that did 281 remain stained positive for Hoechst but were negative for Di-I-Ac-LDL. 282 283 LSEC phenotype and proliferation are partially maintained with lipids in growth factor-reduced, 284 serum-free media. 285
Following cell number reduction at day 3, LSEC phenotype was assessed. An important LSEC 286 hallmark is the presence of fenestrae on cell surfaces. Using scanning electron microscopy we 287 found both 50 μM OA and 1% lipid treated LSEC expressed numerous fenestrae at days 3-5 of 288 culture (Figure 4) , while control cells did not maintain fenestrae. Only about 5% of all FFA-289 treated cells expressed fenestrations in sieve plates. A larger percentage (10-15%) expressed 290 large holes ( Figure 4H , I) that are suspected to be sieve plate remnants. When the population was 291 taken as a whole, porosity was well below the 10% observed for healthy LSEC in vivo (7), 292
indicating that FFA alone does not maintain fenestrations at normal levels. 293 294 Another characteristic LSEC marker, CD32b, was used to corroborate phenotype. 295
Immunostained coverslips revealed that cells treated with FFAs maintained CD32b expression at 296 day 5 ( Figure 5A ). Control cells remaining in culture did not have colocalization of CD32b 297 surface expression with nuclei; CD32b appeared as punctate staining which were most likely 298 dead cell remnants. Non-viable adherent cells appeared less frequently in protocols with 299 multiple rinse steps (e.g., Di-I-Ac-LDL uptake, Figure 3C ; co-immunostaining, Figure 5 ; flow 300 cytometry, Figure 6B ). Although we stained for CD31, we did not observe CD31 expression on 301 the cell surfaces of LSEC in FFA-treated conditions or remaining adherent cells in the control 302 unless samples were permeabilized prior to staining ( Figure 5B ). CD32b + cells comprised a 303 greater proportion of total cell populations in lipid treated LSEC in flow cytometry compared to 304 controls ( Figure 6C ). The enhanced presence of CD32b + cells in OA and lipid is consistent with 305 immunostaining results. CD32b staining was still present on day 5 cultures treated with lipid 306 ( Figure 5C ) and OA (not shown), but signal intensity was diminished compared to LSEC 307 evaluated on day 1 following isolation. 308 309 Proliferative capabilities were measured using PCNA and EdU (a BrdU analog) incorporation. 310 OA and lipid treated cells stained positive for both PCNA and CD32b expression at day 5 while 311 untreated cells did not ( Figure 5A ). Most cells were PCNAin the control; those that were 312 PCNA + were CD32b -. Day 5 cells had higher proportions CD32b + / EdU + cells in OA compared 313 to control (Figure 6A, C) . 1% lipid treated LSEC did not have statistically significant 314 CD32b + /EdU + populations over the control. However, this is likely attributed to the culture 315 achieving confluency by days 4 and 5 relative to the OA condition; we were able to obtain a 316 greater number of overall and CD32b + events for 1% lipid samples than with any other 317 condition. Even when debris is included we have statistically significant larger populations of 318 distinct double positive cells following treatment. Combined with immunostaining observations, 319 we can state that PCNA observed in untreated conditions most likely stems from contaminating 320 cell types and/or dedifferentiated LSEC. 321
322
Temporal dependence of LSEC on PI3K and MAPK pathways observed at Days 3 and 5 in FFA-323 treated cultures. 324 Akt and ERK1/2 proteins were probed on days 3 and 5 by Western blotting, as significant 325 phenotypic changes occurred at these times ( Figure 7A, B) . Signaling trends observed for Akt 326 and ERK1/2 were consistent across biological replicates. Phospho-Akt/Akt ratios decreased 327 dramatically by day 5 in OA and lipid treated LSEC. Day 3 total and phospho-ERK1/2 levels 328 were similar for all conditions but increased by day 5 in OA and lipid treated LSEC. Phospho-329 ERK/ERK ratios remained relatively unchanged for ERK2 but increased by day 5 for ERK1, 330 indicating ERK1 as the primary contributor to overall phospho-ERK/ERK in OA and lipid 331 cultures. Despite no observable statistical significance for phospho-protein signals in Western 332 blots, we found a temporal significance with regard to total signaling proteins present at days 3 333 and 5 compared to control conditions. Total Akt was statistically significant at days 3 (p<0.05) 334
and 5 for OA (p<0.05) and day 5 lipid (p<0.05) conditions, while total ERK1 (p44) was 335 statistically significant at day 5 (p<0.05) compared to control. Phospho-Akt levels remained 336 relatively constant across all conditions and times, while total Akt increased in treated conditions 337 compared to control through day 5. 338 339 Inhibition studies were performed using PI3K inhibitor LY294002 and MEK1/2 inhibitor 340 PD0325901. Inhibitors did not affect LSEC for the first 24 hours of incubation ( Figure 8A, 9A ) 341 despite lower concentrations effectively reducing downstream Akt and ERK1/2 phosphorylation 342 ( Figure 9D ). By day 2, 10 μM PI3K inhibitor had adverse effects despite addition of OA or lipid 343 ( Figure 8B, 9A-C) . Lower PI3K inhibitor concentrations (3 μM) showed similar effects in 344 unsupplemented medium, but cultures with OA or lipid survived while only the lipid condition 345 continued to proliferate ( Figure 8B, 9B, C) . High MEK1/2 inhibitor concentrations only slightly 346 affected OA conditions at day 2 by reducing attached cell number, although culture quality 347 appeared similar to treatments without inhibitor. Lipid cultures did not appear to be perturbed by 348 1 μM MEK1/2 inhibitor by day 2. MEK1/2 inhibition prevented culture survival after day 4 349 ( Figure 8C To test our hypothesis on the requirement of lipids to maintain LSEC viability, we evaluated 355 several different types of lipids in both regular and FFA-free BSA. FFA-free BSA permitted 356 individual testing of lipids for effects on LSEC culture, since native albumin exists bound to a 357 variety of FFAs (4). By day 5, we observed that LSEC cultured with FFAs maintained metabolic 358 and endocytic activity, and proliferated to confluency. The particular form of lipids delivered to 359 LSEC was important, since membrane lipids PC and LPC did not maintain viability. PC and 360 LPC can facilitate cell signaling and stimulate proliferation in many cell types (2, 42), but did not 361 maintain LSEC in culture. We observed that OA alone was insufficient for supporting long-term 362 culture in FFA-free BSA, although OA could recapitulate the lipid supplement effects in regular 363 BSA. In comparison, the 1% lipid supplement, a cocktail of saturated and unsaturated FFAs, 364 was able to support LSEC viability regardless of the BSA used, affirming the necessity for a 365 variety of FFAs to sustain survival and proliferation. 366 367 A hallmark of LSEC is the presence of fenestrae, which were maintained in both OA and lipid 368 samples on day 5. Of the few living cells remaining in the control, none were found to possess 369 fenestrae, consistent with previous findings that fenestrae disappear within the first 48 hours of 370 culture (7). Additional evaluation with CD32b phenotype marker validated findings that 371 surviving LSEC in lipid or OA maintained differentiation by expressing this marker, one specific 372 to liver sinusoidal endothelium (37). Along with CD32b expression, we also looked at the 373 proliferative capacity of LSEC, since no previous studies have explicitly reported that 374 differentiated rat LSEC can undergo proliferation. We successfully demonstrated that 375 differentiated LSEC undergo proliferation, via nuclear PCNA expression and EdU incorporation, 376 when treated with FFAs. Despite maintenance of several phenotypic characteristics in prolonged 377 cultures, we did observe degradation of some markers. Although fenestrae arranged in sieve 378 plates were observed, they were not abundant in OA and lipid treated cultures, and a large 379 percentage of these LSEC no longer exhibited fenestrae by day 5. Many cells in the FFA-treated 380 condition processed large transcytotic pores greater that 1 μm in diameter. These may be the 381 remnants of sieve plates that have degraded or fenestrae that have fused. We noticed that 382 although LSEC still expressed CD32b, the presence was diffuse and overall fluorescent intensity 383 was lower than for freshly isolated LSEC ( Figure 5C ). Other studies have reported sharper 384 declines in specific LSEC phenotype markers during culture, mostly associated with the 385 dedifferentiation process, recently reported to involve 37) . We suspect that lipid-386 treated LSEC maintain a state of differentiation that allows them to persist and proliferate in 387 vitro, but do not maintain physiological levels of CD32b antigen or fenestrations. 388
389
In LSEC we observed phospho-Akt/Akt levels decreased in FFA conditions as time progressed, 390 while the inverse occurred with phospho-ERK/ERK, primarily by ERK1. From these 391 observations and inhibitor studies, we believe low threshold levels of phospho-Akt are required 392 for cell survival between days 2 and 3. At this point, high concentrations of PI3K inhibitor 393 LY294002 abolished the beneficial effects that OA and 1% lipid have on LSECs, while lower 394 concentrations did not affect cultures. Beyond 3 days, cells in low PI3K inhibitor could 395 proliferate and recover albeit not to the level seen in uninhibited samples. Granular morphology 396 appeared earlier at day 2 (as opposed to day 3 in control samples without inhibitor) in untreated 397 samples with PI3K inhibitor. This may indicate that downstream signals of PI3K are closely 398 associated with cell survival during this time. Past day 3, MEK1/2 inhibition was fatal to 399 cultures, as LSEC did not survive or proliferate regardless of the concentration of MEK1/2 400 inhibitor PD0325901 added to cultures. Interestingly, OA and lipid-treated cultured LSEC did 401 not have a significant dependence on MAPK before this time, as 10 μM inhibitor only slightly 402 affected the number of cells in culture. At early time points, MEK1/2 inhibition also prevented 403
LSECs from undergoing increased spreading seen with FFA treatments. As such, MAPK 404 signaling may be partially responsible for the morphology change induced by FFAs before day 3, 405 but required afterward for survival and proliferation. 406
407
While it is understood that ECM, cell-cell contacts (37), and paracrine/autocrine signaling (17) 408 are absolutely vital to achieve functional LSEC, consideration of the role of lipids is important 409
given the results of this study. Effects of FFAs on LSEC can have several implications on liver 410 pathophysiology. In general, lipids are crucial for survival for all mammalian cells as energy 411 substrates, membrane lipid bases, and influencing cell signal processes (3).
Concentrations of 412
FFAs in circulation can vary dramatically depending on the metabolic state, but have been 413 reported to be anywhere between 10 μM to 1 mM in human plasma, though generally within the 414 range of 200 to 600 μM (25, 44, 45) . Approximately 150 μM total plasma FFA is taken up in the 415 liver, of which about 50 μM is comprised of OA (and is recapitulated in our experimental 416 conditions) (25, 30) . The liver is the primary organ responsible for lipid metabolism as 75% of 417 the blood that enters into the liver arrives from the intestine which absorbs lipids from the gut or 418 lipolysis from adipose tissue (10). Thus, FFAs are likely to have a profound influence on LSEC. 419
Past studies have shown that polyunsaturated FFAs can protect hepatocytes from superoxide 420 radicals (49), while bioactive lipids like sphingosine 1-phosphate provide oxidative protection to 421 LSEC following liver injury (57). In contrast, studies also argue for the presence of lipids as 422 precursors to chronic disease, apoptosis, steatosis, and insulin resistance/diabetes (1, 33, 35, 36) . 423
For example, caveolin-1 is important to lipid metabolism during liver regeneration, but may also 424 implicate a role of pathogenesis in LSEC since it is upregulated in dedifferentiating cells (8, 10, 425 50 MAPK and PI3K (12, 13, 52, 53, 55, 56) . However, much of the data from previous 433 studies are contradictory in either stimulating or inhibiting these pathways dependent on the 434 system being studied. 435 436 Unsaturated FFAs have been found to be able to protect against oxidative stress by reducing lipid 437 peroxidation and inhibiting the inflammatory pathway NF-κB which can lead to endothelial cell 438 activation (9, 11, 15, 39) . Thus, OA may prevent oxidative stress in LSEC that decreases ERK1/2 439 activity (38, 48), thereby allowing cells to resume cell survival and proliferation after day 3. This 440 would be in agreement with the results we observed in increased phospho-ERK1/2 activity. 441 Furthermore, increased saturated to unsaturated fatty acid levels are strongly correlated with 442 insulin resistance and decreased glucose production in the liver (33, 36 activity. Phospho-and total protein blots were performed for Akt and ERK at days 3 and 5 708 (representative shown (A)). Signaling trends observed for Akt and ERK1/2 were consistent 709 across biological replicates. Replicates and pixel intensity data were analyzed using ImageJ and 710 plotted against control after normalizing to β-actin values (B). OA and lipid conditions had 711 higher phospho-ERK1/total phospho-ERK1 ratios than in control. Phospho-Akt/total Akt ratios 712 were lower in OA and lipid conditions than in control. Total Akt increased in OA and lipid 713 conditions (p<0.05 from control at days 3 and 5), while total ERK1 increased at day 5 (p<0.05 714 from control). 715 716 Figure 8. Oleic acid and lipid supplement support cultures through early maintenance of low 717 threshold of phospho-Akt followed by late phosho-ERK signaling. Cells were cultured in 718 identical conditions with PI3K inhibitor (LY294002 1 or 10 μM) or MEK1/2 inhibitor 719 (PD0325901 0.3 or 1 μM) for 7 days. Drug inhibitors had no significant effects on cell cultures 720 following the first day of drug inhibitor treatment (A). Significant cell integrity loss was 721 observed in LSECs with 10 μM PI3K inhibitor, with less pronounced effects in 1 μM PI3K 722 inhibitor by day 2, while MEK1/2 inhibitor started to affect oleic acid cultures but not 1% lipid 723 treated SECs (B). SECs in oleic acid or 1% lipid were able to maintain culture viability by days 4 724 and beyond in culture despite low PI3K inhibitor concentrations (C,D). MEK1/2 inhibitor did 725 eventually affect lipid treated SECs by day 4 (C), although many cells managed to survive in low 726 
